Edition:
United States

Tenax Therapeutics Inc (TENX.OQ)

TENX.OQ on NASDAQ Stock Exchange Capital Market

6.91USD
4:00pm EDT
Change (% chg)

$0.24 (+3.60%)
Prev Close
$6.67
Open
$6.62
Day's High
$6.94
Day's Low
$6.57
Volume
1,081
Avg. Vol
29,002
52-wk High
$15.50
52-wk Low
$4.42

Chart for

About

Tenax Therapeutics, Inc. is a specialty pharmaceutical company. The Company is focused on identifying, developing and commercializing products for the critical care market. The Company's main product is levosimendan. Levosimendan is a calcium sensitizer developed for intravenous use in hospitalized patients with acutely... (more)

Overall

Beta: 1.92
Market Cap(Mil.): $14.39
Shares Outstanding(Mil.): 28.24
Dividend: --
Yield (%): --

Financials

  TENX.OQ Industry Sector
P/E (TTM): -- 85.48 32.76
EPS (TTM): -1.43 -- --
ROI: -114.61 2.29 14.61
ROE: -129.29 3.86 16.34

BRIEF-Tenax Therapeutics Files For Mixed Shelf Of Up To $75 Mln

* TENAX THERAPEUTICS INC FILES FOR MIXED SHELF OF UP TO $75 MILLION – SEC FILING Source text: (http://bit.ly/2rK4oYR) Further company coverage:

May 15 2018

Competitors

  Price Chg
Novartis AG (NOVN.S) CHF78.20 -0.46
Merck & Co., Inc. (MRK.N) $62.53 -0.06
Roche Holding Ltd. (ROG.S) CHF232.00 -0.25
Roche Holding Ltd. (RO.S) CHF236.80 +0.20
Abbott Laboratories (ABT.N) $62.80 +1.02
Bayer AG (BAYGn.DE) €93.41 +0.24
Bayer AG (BAYE.F) -- --
Sanofi SA (SASY.PA) €71.84 --
Eli Lilly And Co (LLY.N) $89.57 +0.50
Bristol-Myers Squibb Co (BMY.N) $56.63 +0.20

Earnings vs. Estimates